Pharmacists still cannot prescribe the medication themselves, a step that would cut the time it takes patients to secure the drug.
The Food and Drug Administration “is looking at this and thinking about it,” Dr. Jha said. “Whether they’re going to make a change, when and how, etc., is totally in their wheelhouse.”
Many patients are still handling the sometimes-cumbersome steps on their own: locating a virus test, then securing a Paxlovid prescription from a health provider, then finding a pharmacy that carries the pill, all within days of first showing symptoms.
Dr. Jha described being frustrated by physician colleagues who have told him they still limit Paxlovid to patients 65 years and older.
But no they still will not do this. I repeat myself, but you need to keep in mind the only time panel members have resigned from the FDA is when the Biden administration pushed through the booster shots.
Here is the full NYT article, via Rich Berger.